ARA-290

🧬 Core Mechanisms:

• Innate Repair Receptor (IRR) Agonism: Functions as a synthetic 11-amino acid peptide derived from the helix B domain of erythropoietin (EPO). It selectively binds to the Innate Repair Receptor (the $EPOR\text{-}\beta cR$ heterocomplex) expressed primarily on tissues undergoing active injury or metabolic stress.

• Selective Non-Erythropoietic Path Modulation: Activates tissue protection, survival, and structural repair mechanisms without binding to the classic erythropoietin homodimer, completely avoiding the dangerous stimulation of red blood cell mass (erythropoiesis) or blood viscosity.

🌟 Why Choose ARA-290?

• Advanced Small Fiber Neuropathy Repair: Widely researched for its unique ability to regenerate damaged small, unmyelinated nerve fibers, effectively targeting neuropathic pain, loss of sensation, and autonomic dysfunction at the structural level.

• Profound Inflammatory Cascade Suppression: Strongly blocks the activation of the NLRP3 inflammasome and suppresses the production of pro-inflammatory cytokines (such as $TNF\text{-}\alpha$ and $IL\text{-}6$), acting as a master regulator against chronic systemic inflammation.

• Accelerated Ischemic & Wound Recovery: Enhances localized microvascular perfusion and cell survival, demonstrating superior capabilities in salvaging tissues damaged by chronic ischemia, diabetic complications, and metabolic stress cycles.

• ---

  Note: All products are intended for laboratory and scientific research purposes only. Not FDA-approved. Not for human or animal consumption